SCHEMBL1820199

SCHEMBL1820199

O=C(O)CC=CC1(c2ccccc2F)CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 5/20 0.44
PAM P19021 1/20 0.38
MAPT P10636 2/20 0.37
THRB P10828 1/20 0.37
PSEN1 P49768 2/20 0.36
PSEN2 P49810 2/20 0.36
APH1B Q8WW43 2/20 0.36
NCSTN Q92542 2/20 0.36
APH1A Q96BI3 2/20 0.36
PSENEN Q9NZ42 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
HSD11B1 P28845 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872760 1.00 HDAC4 (0.44) HDAC4PAMMAPTTHRBPSEN1
SCHEMBL433694 0.77 HSD11B1 (0.54) ALDH1A1HSD11B1
SCHEMBL433257 0.77 HSD11B1 (0.54) ALDH1A1HSD11B1
SCHEMBL30929499 0.73 HDAC4 (0.44) HDAC4GAAALDH1A1OPRM1OPRD1
SCHEMBL15043672 0.72 HDAC4 (0.42) HDAC4MAPTTHRBPSEN1PSEN2
SCHEMBL2867660 0.71 HDAC4 (0.65) HDAC4MAPTTHRBPSEN1PSEN2
SCHEMBL29567033 0.71 HDAC4 (0.65) HDAC4MAPTTHRBPSEN1PSEN2
SCHEMBL15042455 0.69 HDAC4 (0.40) HDAC4MAPTPSEN1PSEN2APH1B
SCHEMBL625059 0.69 HDAC4 (0.45) HDAC4PSEN1PSEN2APH1BNCSTN
SCHEMBL31580968 0.69 HDAC4 (0.67) HDAC4MAPTTHRBPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493866-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS Bristol-Myers Squibb Company (US) 2012-09-05 EP disclosed
WO-2011059784-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed